Who could submit an application to the Longitude Prize on ALS?

Applications were open to potential innovators from a range of sectors, including:

• The global ALS research community,

• The neurodegeneration research community, particularly those working in FTD, Dementia, Parkinson's etc,

• Academics specialising in AI/ML for health,

• All Biotech, Techbio and Pharma currently active in the ALS or neurodegenerative space,

• Biotech and Techbio, not presently active in ALS.

To enter the Prize, applicants had to meet these eligibility criteria:

• The prize was open to organisations worldwide, including academic groups, companies or non-profits, as well as partnerships between these. Individuals could not enter. 

• Entries had to be in English.

• Applicants had to comply with the Prize Terms & Conditions (T&Cs; please see here for details).